Published May 2, 2012 | Version v1
Journal article Open

Noninvasive molecular imaging of neuroinflammation

  • 1. European Institute for Molecular Imaging (EIMI) at the Westfalian Wilhelms-University of Mu¨nster (WWU), Mu¨nster, Germany; Department of Nuclear Medicine, University Hospital, WWU, Mu¨nster, Germany; Interdisciplinary Center for Clinical Research (IZKF), WWU, Mu¨nster, Germany
  • 2. CEA, I2BM, SHFJ, Orsay, France

Description

Inflammation is a highly dynamic and complex adaptive process to preserve and restore tissue homeostasis. Originally viewed as an immune-privileged organ, the central nervous system (CNS) is now recognized to have a constant interplay with the innate and the adaptive immune systems, where resident microglia and infiltrating immune cells from the periphery have important roles. Common diseases of the CNS, such as stroke, multiple sclerosis (MS), and neurodegeneration, elicit a neuroinflammatory response with the goal to limit the extent of the disease and to support repair and regeneration. However, various disease mechanisms lead to neuroinflammation (NI) contributing to the disease process itself. Molecular imaging is the method of choice to try to decipher key aspects of the dynamic interplay of various inducers, sensors, transducers, and effectors of the orchestrated inflammatory response in vivo  in animal models and patients. Here, we review the basic principles of NI with emphasis on microglia and common neurologic disease mechanisms, the molecular targets which are being used and explored for imaging, and molecular imaging of NI in frequent neurologic diseases, such as stroke, MS, neurodegeneration, epilepsy, encephalitis, and gliomas.

Files

JacobsTavitian_JCBFMOpen_2012_P01.pdf

Files (708.7 kB)

Name Size Download all
md5:aa0559f1260408987b5502beb9af8418
708.7 kB Preview Download

Additional details

Related works

Is supplement to
10.1038/jcbfm.2012.53 (DOI)

Funding

INMIND – Imaging of Neuroinflammation in Neurodegenerative Diseases 278850
European Commission